Results 161 to 170 of about 30,028 (235)

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and "Heterozygous FH Score" from FAME Study. [PDF]

J Atheroscler Thromb, 2022
Nohara A.
europepmc   +1 more source

Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene Duplication. [PDF]

JACC Case Rep
Pindwarawala M, Bose S, Brunham LR.
europepmc   +1 more source

Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.

Journal of the American Medical Association (JAMA), 2016
Dhruv S. Kazi, A. Moran, P. Coxson, J. Penko, D. Ollendorf, S. Pearson, J. Tice, D. Guzman, K. Bibbins‐Domingo   +8 more
semanticscholar   +1 more source

Efficacy and outcomes of inclisiran in the management of homozygous and heterozygous familial hypercholesterolemia: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Khan Z, Singh A, Haseeb Ur Rasool M, Qasim N, Yafaa Naveed Chaudhary M, Syed S, Riaz M, Rehman W, Rehman I, Islam R, Islam H, Muhammad A, Devi R, Wei CR, Naaz F, Akilimali A.   +15 more
europepmc   +1 more source

Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia. [PDF]

Life (Basel)
Cefalù AB, Nardi E, Giammanco A, Gagliardo CM, Barbagallo CM, La Grutta L, Toia P, Brucato F, Scrimali C, Fasciana TMG, Spina R, Lanza M, Vitale F, Noto D, Averna M.   +14 more
europepmc   +1 more source

Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia. [PDF]

J Transl Med, 2021
Liu MM, Peng J, Guo YL, Zhu CG, Wu NQ, Xu RX, Dong Q, Li JJ.   +7 more
europepmc   +1 more source

<i>Proprotein Convertase Subtilisin</i>/<i>Kexin Type 9</i> (<i>PCSK9</i>) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia. [PDF]

Int J Mol Sci
Woźniak E, Woźniak A, Pawlos A, Broncel M, Satała J, Bukowska B, Gorzelak-Pabiś P.   +6 more
europepmc   +1 more source

Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors. [PDF]

Int J Mol Sci
Climent E, González-Guerrero A, Marco-Benedí V, García-Andreu MD, Mediavilla-García JD, Suárez-Tembra M, Benaiges D, Pintó X, Pedro-Botet J.   +8 more
europepmc   +1 more source

Adherence to the Healthy Nordic Food Index is associated with reduced plasma levels of inflammatory markers in patients with heterozygous familial hypercholesterolemia. [PDF]

Atheroscler Plus
Løvheim EB, Retterstøl K, Narverud I, Bogsrud MP, Halvorsen B, Ueland T, Aukrust P, Holven KB.   +7 more
europepmc   +1 more source